185 related articles for article (PubMed ID: 20038193)
1. Inpatient costs of endophthalmitis evaluated for the whole of France.
Colin X; Berdeaux G; Lafuma A; Salvanet-Bouchara A; Kodjikian L
Appl Health Econ Health Policy; 2010; 8(1):53-60. PubMed ID: 20038193
[TBL] [Abstract][Full Text] [Related]
2. Management of venous thromboembolism in cancer patients: the economic burden of hospitalizations.
Mahé I; Mayeur D; Krakowski I
Support Care Cancer; 2016 Oct; 24(10):4105-12. PubMed ID: 27146390
[TBL] [Abstract][Full Text] [Related]
3. Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database.
Uhart M; Blein C; L'Azou M; Thomas L; Durand L
Eur J Health Econ; 2016 May; 17(4):497-503. PubMed ID: 25962729
[TBL] [Abstract][Full Text] [Related]
4. Heparin-induced thrombocytopenia: an estimate of the average cost in the hospital setting in France.
Elalamy I; Le Gal G; Nachit-Ouinekh F; Lafuma A; Emery C; Le-Fur C; Chapuis F
Clin Appl Thromb Hemost; 2009; 15(4):428-34. PubMed ID: 18544593
[TBL] [Abstract][Full Text] [Related]
5. Costs associated with hospitalization in HIV-positive patients in France.
de Léotoing L; Yazdanpanah Y; Finkielsztejn L; Chaize G; Vainchtock A; Nachbaur G; Aubin C; Bonnet F
AIDS; 2018 Sep; 32(14):2059-2066. PubMed ID: 29894390
[TBL] [Abstract][Full Text] [Related]
6. Economic and organizational impact of the changing hospital funding practices of erythropoiesis-stimulating agents on the management of care of dialysis patients in France.
Therasse C; Fusier I; Cordonnier AL; Bérard F; de Curzon OP; Bocquet F; Paubel P
J Comp Eff Res; 2018 Jun; 7(6):569-580. PubMed ID: 29537304
[TBL] [Abstract][Full Text] [Related]
7. Burden of anemia in patients with osteoarthritis and rheumatoid arthritis in French secondary care.
Zlateva G; Diazaraque R; Viala-Danten M; Niculescu L
BMC Geriatr; 2010 Aug; 10():59. PubMed ID: 20796267
[TBL] [Abstract][Full Text] [Related]
8. Cost of single-vessel and multivessel coronary drug-eluting stenting: comparison to the DRG funding level.
Varani E; Balducelli M; Gatti C; Tesselli MR; Vecchi G; Maresta A
Ital Heart J; 2005 Jan; 6(1):52-8. PubMed ID: 15773274
[TBL] [Abstract][Full Text] [Related]
9. Evaluating outpatient versus inpatient costs in endophthalmitis management.
Sulkes DJ; Scott IU; Flynn HW; Feuer WJ
Retina; 2002 Dec; 22(6):747-51. PubMed ID: 12476101
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases.
Heng C; Rybarczyk-Vigouret MC; Michel B
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):144-51. PubMed ID: 25079654
[TBL] [Abstract][Full Text] [Related]
11. Positive predictive values of selected hospital discharge diagnoses to identify infections responsible for hospitalization in the French national hospital database.
Sahli L; Lapeyre-Mestre M; Derumeaux H; Moulis G
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):785-9. PubMed ID: 27125251
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Drug Use-Related Endogenous Endophthalmitis Hospitalizations in the United States, 2003 to 2016.
Mir TA; Papudesu C; Fang W; Hinkle DM
JAMA Ophthalmol; 2021 Jan; 139(1):18-26. PubMed ID: 33151291
[TBL] [Abstract][Full Text] [Related]
13. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
Cotté FE; Chaize G; Kachaner I; Gaudin AF; Vainchtock A; Durand-Zaleski I
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e73-83. PubMed ID: 24119623
[TBL] [Abstract][Full Text] [Related]
14. Identification of a pulmonary arterial hypertension (PAH) patient cohort and study of its burden of illness in Programme de Médicalisation des Systèmes d'information (PMSI).
Exposto F; Petrică N; Davies E; Beaudet A
Int J Cardiol; 2020 May; 306():175-180. PubMed ID: 32113663
[TBL] [Abstract][Full Text] [Related]
15. Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment).
Fernandes J; Bregman B; Combemale P; Amaz C; de Léotoing L; Vainchtock A; Gaudin AF
BMC Health Serv Res; 2017 Aug; 17(1):542. PubMed ID: 28789648
[TBL] [Abstract][Full Text] [Related]
16. [Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution].
Couffignal AL; Lapeyre-Mestre M; Bonhomme C; Bugat R; Montastruc JL
Therapie; 2000; 55(5):635-41. PubMed ID: 11201979
[TBL] [Abstract][Full Text] [Related]
17. [Dermatology day-care: between official rules and reality].
Ingen-Housz-Oro S; Durand-Zaleski I; Cosnes A; Valeyrie-Allanore L; Moreno JC; Chosidow O; Wolkenstein P
Ann Dermatol Venereol; 2012 Nov; 139(11):701-9. PubMed ID: 23199765
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis of adverse events associated with non-small cell lung cancer management in France.
Chouaid C; Loirat D; Clay E; Millier A; Godard C; Fannan A; Lévy-Bachelot L; Angevin E
Clinicoecon Outcomes Res; 2017; 9():443-449. PubMed ID: 28794648
[TBL] [Abstract][Full Text] [Related]
19. Economic burden of osteoporosis in women: data from the 2008 French hospital database (PMSI).
Maravic M; Jouaneton B; Vainchtock A; Tochon V
Clin Exp Rheumatol; 2012; 30(2):222-7. PubMed ID: 22546070
[TBL] [Abstract][Full Text] [Related]
20. [Economic burden of Clostridium difficile enterocolitis in German hospitals based on routine DRG data].
Grube RF; Heinlein W; Scheffer H; Rathmayer M; Schepp W; Lohse AW; Stallmach A; Wilke MH; Lerch MM;
Z Gastroenterol; 2015 May; 53(5):391-7. PubMed ID: 25965986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
